242 related articles for article (PubMed ID: 17981226)
1. The role of the woodchuck model in the treatment of hepatitis B virus infection.
Kulkarni K; Jacobson IM; Tennant BC
Clin Liver Dis; 2007 Nov; 11(4):707-25, vii. PubMed ID: 17981226
[TBL] [Abstract][Full Text] [Related]
2. Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection.
Wang BJ; Tian YJ; Meng ZJ; Jiang M; Wei BQ; Tao YQ; Fan W; Li AY; Bao JJ; Li XY; Zhang ZM; Wang ZD; Wang H; Roggendorf M; Lu MJ; Yang DL
J Gen Virol; 2011 Mar; 92(Pt 3):681-91. PubMed ID: 21084496
[TBL] [Abstract][Full Text] [Related]
3. Fluctuation of the cytokine expression in the liver during the chronic woodchuck hepatitis virus (WHV) infection is not related to viral load.
Schildgen O; Fiedler M; Dahmen U; Li J; Lohrengel B; Lu M; Roggendorf M
Immunol Lett; 2006 Jan; 102(1):31-7. PubMed ID: 16046239
[TBL] [Abstract][Full Text] [Related]
4. Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.
Liu CJ; Huang YJ; Chen HL; Lin HT; Lin HL; Kuo ML; Huang JL; Chen DS; Chen PJ; Wu HL
Genes Immun; 2009 Jan; 10(1):27-36. PubMed ID: 18971938
[TBL] [Abstract][Full Text] [Related]
5. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
Korba BA; Xie H; Wright KN; Hornbuckle WE; Gerin JL; Tennant BC; Hostetler KY
Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
[TBL] [Abstract][Full Text] [Related]
6. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
7. In vitro activation of woodchuck lymphocytes measured by radiopurine incorporation and interleukin-2 production: implications for modeling immunity and therapy in hepatitis B virus infection.
Cote PJ; Gerin JL
Hepatology; 1995 Sep; 22(3):687-99. PubMed ID: 7544755
[TBL] [Abstract][Full Text] [Related]
8. Lack of WHV integration nearby N-myc2 and in the downstream b3n and win loci in a considerable fraction of liver tumors with activated N-myc2 from naturally infected wild woodchucks.
Bruni R; Conti I; Villano U; Giuseppetti R; Palmieri G; Rapicetta M
Virology; 2006 Feb; 345(1):258-69. PubMed ID: 16271377
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of woodchuck interleukin 15 (wIL-15) and detection of its expression in liver samples of woodchucks infected with woodchuck hepatitis virus (WHV).
Wang B; Lohrengel B; Lu Y; Meng Z; Xu Y; Yang D; Roggendorf M; Lu M
Cytokine; 2005 Dec; 32(6):296-303. PubMed ID: 16406557
[TBL] [Abstract][Full Text] [Related]
10. Pre-acute hepadnaviral infection is associated with activation-induced apoptotic death of lymphocytes in the woodchuck (Marmota monax) model of hepatitis B.
Gujar SA; Jenkins AK; Macparland SA; Michalak TI
Dev Comp Immunol; 2010 Sep; 34(9):999-1008. PubMed ID: 20451550
[TBL] [Abstract][Full Text] [Related]
11. Infection Patterns Induced in Naive Adult Woodchucks by Virions of Woodchuck Hepatitis Virus Collected during either the Acute or Chronic Phase of Infection.
Freitas N; Lukash T; Rodrigues L; Litwin S; Kallakury BV; Menne S; Gudima SO
J Virol; 2015 Sep; 89(17):8749-63. PubMed ID: 26063428
[TBL] [Abstract][Full Text] [Related]
12. Animal models of hepatocellular carcinoma: hepadnavirus-induced liver cancer in woodchucks.
Ponzetto A; Forzani B
Ital J Gastroenterol; 1991 Nov; 23(8):491-3. PubMed ID: 1751825
[TBL] [Abstract][Full Text] [Related]
13. The woodchuck: a model for therapeutic vaccination against hepadnaviral infection.
Roggendorf M; Yang D; Lu M
Pathol Biol (Paris); 2010 Aug; 58(4):308-14. PubMed ID: 20646874
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology.
Zahm FE; Bonino F; Giuseppetti R; Rapicetta M
Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):510-6. PubMed ID: 9836108
[TBL] [Abstract][Full Text] [Related]
15. Hepadnavirus-induced liver cancer in woodchucks.
Gerin JL; Cote PJ; Korba BE; Tennant BC
Cancer Detect Prev; 1989; 14(2):227-9. PubMed ID: 2695243
[TBL] [Abstract][Full Text] [Related]
16. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
Wang J; Gujar SA; Cova L; Michalak TI
J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
Roggendorf M; Schulte I; Xu Y; Lu M
J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
[TBL] [Abstract][Full Text] [Related]
18. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response.
Jacob JR; Ascenzi MA; Roneker CA; Toshkov IA; Cote PJ; Gerin JL; Tennant BC
Hepatology; 1997 Dec; 26(6):1607-15. PubMed ID: 9398005
[TBL] [Abstract][Full Text] [Related]
19. The woodchuck model of hepatitis B virus infection.
Tennant BC; Gerin JL
ILAR J; 2001; 42(2):89-102. PubMed ID: 11406711
[TBL] [Abstract][Full Text] [Related]
20. Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection.
Coffin CS; Pham TN; Mulrooney PM; Churchill ND; Michalak TI
Hepatology; 2004 Nov; 40(5):1053-61. PubMed ID: 15382154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
